Real-time enrollment status for this pyoderma gangrenosum clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 3:06 PM UTC
| NCT Number | NCT06624670 |
| Recruiting Status | Recruiting |
| Condition | Pyoderma Gangrenosum |
| Phase | PHASE3 |
| Target Enrollment | 90 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | August 3, 2026 (4 weeks ago) |
As of August 31, 2026: Clinical trial NCT06624670 is currently recruiting participants. This phase3 study for pyoderma gangrenosum is actively seeking new participants at 23 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06624670 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06624670 was last updated 4 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.